How nerves signal the body in health and overweight
Part of Hormones & metabolism clinical trials.
This study looks at how your brain sends signals to your body, comparing healthy people and those who are overweight. You'll help researchers understand differences in nerve communication.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- Your BMI must be between 20 and 24.9 (healthy weight) or over 28 (overweight).
- If you are a woman of childbearing age, you must use a single-phase hormonal contraceptive (like Nuvaring).
- You cannot smoke or have a history of drug or alcohol abuse.
- You cannot take certain medications that affect blood sugar or the nervous system (like antidepressants, beta blockers, or seizure drugs).
- You cannot have heart, neurological, or certain other medical conditions (like glaucoma, thyroid problems, or liver/kidney issues).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a GLP-1 receptor agonist (a type of diabetes medicine) changes how the brain responds to insulin in people with different body sizes. It may help understand if this drug can improve brain function related to insulin.
This study looks at how insulin works in the brain and how it affects the immune system when you exercise. It focuses on people who are overweight, and aims to better understand the connection between brain insulin and immune response during physical activity.
This study looks at how a medication that mimics a natural gut hormone affects brain activity related to appetite in people with healthy weight or obesity. It may help researchers find new ways to treat obesity.
This study looks at how people with different body weights digest and process sugar after a meal. Participants will eat a special breakfast and have blood and possibly stool tests to track a safe, low-dose radioactive label in the sugar. The goal is to understand why body weight affects sugar metabolism.
This early-phase study looks at how the body’s hormone signals and nerve control affect insulin release after gastric bypass surgery. It may help researchers understand what drives low blood sugar and how to better monitor or treat it.
This early-stage study tests a new investigational medication in three groups: healthy adults with normal weight, adults who are overweight or obese, and men with type 1 diabetes who are also overweight. The research aims to understand how safe the medication is and how the body processes it.
Hear when a new Autonomic Function trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.